Internal Medicine · Daly City, CA
NPI
1184638645
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
3
Hospital affiliations
1800 Sullivan Ave, Ste 601
Daly City, CA, 94015
Phone (650) 992-2890
Medicare paid, 2024
$169K
2,848 services
Medicare patients, 2024
291
Average age 77
Drug cost, 2024
$1.8M
11,574 prescriptions
Company payments, 2025
$388
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yin-Yin Myint was code J0897 (injection, denosumab, 1 mg), 1,080 times for 12 patients. In total Yin-Yin Myint billed 2,848 services in 26 codes, and Medicare paid $169K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-10-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,080 | 12 | $20.12 | $22K |
| 99214 Office E&M - Established | Office | 521 | 253 | $102.92 | $54K |
| 99213 Office E&M - Established | Office | 265 | 141 | $75.73 | $20K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 205 | 205 | $155.77 | $32K |
| G0008 Administration of influenza virus vaccine | Office | 177 | 177 | $38.68 | $6,846 |
| 90662 Vaccine Product | Office | 158 | 158 | $81.82 | $13K |
| 96372 Injection Administration | Office | 34 | 20 | $12.50 | $425 |
| 90746 Vaccine Product | Office | 26 | 14 | $68.97 | $1,793 |
| G0010 Administration of hepatitis b vaccine | Office | 26 | 14 | $38.68 | $1,006 |
| 93000 Electrocardiogram | Office | 25 | 24 | $12.80 | $320 |
| G0009 Administration of pneumococcal vaccine | Office | 23 | 23 | $38.68 | $890 |
| 90658 Vaccine Product | Office | 19 | 19 | $21.42 | $407 |
| 99204 Office E&M - New | Office | 17 | 17 | $116.03 | $1,973 |
| 90671 Vaccine Product | Office | 16 | 16 | $248.49 | $3,976 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 12 | 12 | $196.32 | $2,356 |
By year: 2022 $161K for 2,930 services; 2023 $163K for 2,756 services; 2024 $169K for 2,848 services.
Medicare prescription drug claims, 2024
In 2024, the drug Yin-Yin Myint prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,222 prescriptions and refills. In total Yin-Yin Myint wrote 11,574 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,222 | 3,540 | 348 | $27K |
| Losartan Potassium Generic | 1,018 | 2,955 | 293 | $16K |
| Amlodipine Besylate Generic | 818 | 2,354 | 240 | $7,037 |
| Rosuvastatin Calcium Generic | 531 | 1,563 | 158 | $24K |
| Metformin Hcl Er Metformin Hcl | 316 | 902 | 95 | $6,306 |
| Metoprolol Succinate Generic | 276 | 808 | 87 | $4,375 |
| Arexvy Rsvpref3 Antigen/As01e/Pf | 266 | 266 | 264 | $82K |
| Escitalopram Oxalate Generic | 254 | 754 | 83 | $7,318 |
| Metformin Hcl Generic | 221 | 649 | 65 | $2,996 |
| Omeprazole Generic | 212 | 621 | 89 | $5,005 |
| Labetalol Hcl Generic | 205 | 590 | 61 | $7,031 |
| Levothyroxine Sodium Generic | 200 | 556 | 53 | $3,065 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 199 | 344 | 70 | $211K |
| Lisinopril Generic | 185 | 514 | 51 | $2,002 |
| Tamsulosin Hcl Generic | 174 | 506 | 50 | $4,916 |
Brand drugs: 1,792 claims; generic drugs: 9,742 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yin-Yin Myint $388 ($388 in general payments such as food, travel and fees) from 4 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $267.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.